Immunovant (NASDAQ:IMVT) advances autoimmune research as nasdaq today reflects activity across clinical-stage biotech ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

The devastating consequences of mucopolysaccharidosis II (MPS II), also called Hunter syndrome, may soon become preventable ...

Trey Kukuk completó un pase de touchdown antes de realizar un gran acarreo que dejó lista la escena para que Andrew Burnette ...

A man died after he started getting severe headaches and losing his appetite. Kieran Shingler, 26, started feeling unwell on ...

A Cheshire man died after he started getting severe headaches and losing his appetite. Kieran Shingler, 26, started feeling ...

Tividenofusp alfa is composed of IDS fused to Denali’s TransportVehicle™ platform and is engineered to cross the blood-brain barrier, aiming to treat neurological manifestations of MPS II in addition ...

Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Kieran Shingler was just 26 years old when he died earlier this month after being diagnosed with an aggressive brain tumour ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A man tragically died after he started experiencing severe headaches and a loss of appetite.